AAAshwini Rahul Akkineni

Ashwini Rahul Akkineni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashwini Rahul Akkineni has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Michael Gelinsky

    Centre for Translational Bone, Joint and Soft Tissue Research, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany

    11 shared publications
  • Anja Lode

    Centre for Translational Bone Joint and Soft Tissue Research Faculty of Medicine Technische Universität Dresden Dresden Germany

    6 shared publications
  • Sarah Duin

    Centre for Translational Bone, Joint and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine Technische Universität Dresden Dresden Germany

    3 shared publications
  • Tilman Ahlfeld

    Centre for Translational Bone, Joint and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine at Technische Universität Dresden, Fetscherstr. 74, Dresden 01307, Germany

    3 shared publications
  • Akvilė Gasiūnaitė

    Center for Cell and Gene Therapy, Leiden University Medical Center, Leiden, the Netherlands; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands

    1 shared publication
  • Aldo Roberto Boccaccini

    Institute of Biomaterials University of Erlangen‐Nuremberg Erlangen Germany

    1 shared publication

Latest Publications

  • Open Access

    Oxygen Supply of Islets of Langerhans by Photosynthetically Active Microalgae in Bioprinted Co‐Cultures Maintains Their Function in a Hypoxic Environment

    by Finn Dani, Sarah Duin, Ashwini Rahul Akkineni, Susann Lehmann, Barbara Ludwig, Michael Kühl, Michael Gelinsky, Anja Lode

    Type 1 diabetes mellitus (T1D) is characterized by the autoimmune destruction of pancreatic beta cells, leading to insulin deficiency and necessitating lifelong external insulin administration. The transplantation of allogenic islets is a promising therapeutic approach, whereby their macro‐encapsulation offers immune protection but restricts oxygenation after transplantation. This study addresses the challenge of oxygen supply by developing a spatially structured co‐culture system using bioprinting, in which both pancreatic islets and the photosynthetically active microalga Scenedesmus sp. are embedded in alginate‐based hydrogels. Key environmental parameters for long‐term co‐cultivation were developed and systematically optimized: red light illumination was identified as non‐detrimental to islet viability and function while supporting microalgal photosynthesis at the same time, and a co‐culture medium was formulated to fulfill the metabolic requirements of both cell types. In direct co‐culture experiments under hypoxic conditions, microalgae generated sufficient oxygen to maintain normoxic conditions, thereby preserving islet viability and glucose‐stimulated insulin secretion over several days. The results demonstrate that spatially organized bioprinting enables the close proximity of islets and microalgae, facilitating effective oxygen transfer in vitro. This work establishes a robust framework for functional mammalian–microalgae co‐cultures, optimizing conditions to reliably maintain cell health and function through photosynthetically generated oxygen.


  • Open Access

    Uniting 4D Printing and Melt Electrowriting for the Enhancement of Regenerative Small Diameter Vascular Grafts

    by Max von Witzleben, Akvilė Gasiūnaitė, Marlene Ihle, Ashwini Rahul Akkineni, Kathleen Schütz, Tilman Ahlfeld, Michael Gelinsky, Anja Lode, Sarah Duin

    The development of mechanically robust, cell‐instructive, and seweable small‐diameter (≤ Ø 6 mm) tubular scaffolds remain a major challenge in vascular tissue engineering. Here, a hybrid biofabrication strategy is presented that combines 4D printing of alginate‐methylcellulose (AlgMC) hydrogels with melt electrowritten (MEW) poly(ε‐caprolactone) (PCL) reinforcement to produce tubular constructs with programmable shape‐morphing capacity. The MEW fiber meshes significantly improve mechanical integrity, enabling suturing and perfusion, while preserving the anisotropic swelling behavior required for morphogenesis. Scaffold functionalization using human blood‐derived protein coatings — such as fresh frozen plasma, platelet lysate, and fibrinogen — markedly enhances cellular adhesion and fibroblast proliferation without compromising structural transformation. Biological evaluation using mono and co‐cultures of fibroblasts, endothelial cells (HUVEC), and vascular smooth muscle cells (vSMC) reveals the formation of organized bi‐layers and phenotype‐specific cell morphologies on AlgMC/PCL composites. Notably, a confluent endothelial layer promotes contractile marker expression in vSMC, while vSMC support endothelial coverage in the absence of a growth‐arrested fibroblast feeder layer, indicating reciprocal stabilization. While further optimization is needed to meet the demands of small‐diameter vascular grafts fully, the presented system offers a versatile and promising platform for engineering soft tissue constructs that benefit from topographical guidance, spatially controlled adhesion, and adaptive geometry.


  • Open Access

    Recent trends in the development of in vitro 3D kidney models

    by Gaddam Kiranmai, Shibu Chameettachal, Yeleswarapu Sriya, Sarah Duin, Anja Lode, Michael Gelinsky, Ashwini Rahul Akkineni, Falguni Pati

    The kidneys are vital for maintaining bodily homeostasis and are susceptible to various diseases that disrupt their function. Traditionally, research on kidney diseases has relied on animal models and simplistic two-dimensional cell cultures, which do not fully replicate human tissue pathology. To address this, recent advances focus on developing advanced 3D biomimetic in vitro models using human-derived cells. These models mimic healthy and diseased kidney tissues with specificity, replicating key elements like glomerular and tubular structures through tissue engineering. By closely mimicking human physiology, they provide a promising platform for studying renal disorders, drug-induced nephrotoxicity, and evaluating new therapies. However, the challenges include optimizing scalability, reproducibility, and long-term stability to enhance reliability in research and clinical applications. This review highlights the transformative potential of 3D biomimetic in vitro kidney models in advancing biomedical research and clinical applications. By focusing on human-specific cell cultures and tissue engineering techniques, these models aim to overcome the limitations of conventional animal models and simplistic 2D cell cultures. The review discusses in detail the various types of biomimetic kidney models currently under development, their specific applications, and the innovative approaches used to construct them. It also addresses the challenges and limitations associated with these models for their widespread adoption and reliability in research settings.


  • Open Access

    3D bioprinting of mouse pre-osteoblasts and human MSCs using bioinks consisting of gelatin and decellularized bone particles

    by Aylin Kara Özenler, Thomas Distler, Ashwini Rahul Akkineni, Funda Tihminlioglu, Michael Gelinsky, Aldo R Boccaccini

    One of the key challenges in biofabrication applications is to obtain bioinks that provide a balance between printability, shape fidelity, cell viability, and tissue maturation. Decellularization methods allow the extraction of natural extracellular matrix, preserving tissue-specific matrix proteins. However, the critical challenge in bone decellularization is to preserve both organic (collagen, proteoglycans) and inorganic components (hydroxyapatite) to maintain the natural composition and functionality of bone. Besides, there is a need to investigate the effects of decellularized bone (DB) particles as a tissue-based additive in bioink formulation to develop functional bioinks. Here we evaluated the effect of incorporating DB particles of different sizes (≤45 and ≤100 μm) and concentrations (1%, 5%, 10% (wt %)) into bioink formulations containing gelatin (GEL) and pre-osteoblasts (MC3T3-E1) or human mesenchymal stem cells (hTERT-MSCs). In addition, we propose a minimalistic bioink formulation using GEL, DB particles and cells with an easy preparation process resulting in a high cell viability. The printability properties of the inks were evaluated. Additionally, rheological properties were determined with shear thinning and thixotropy tests. The bioprinted constructs were cultured for 28 days. The viability, proliferation, and osteogenic differentiation capacity of cells were evaluated using biochemical assays and fluorescence microscopy. The incorporation of DB particles enhanced cell proliferation and osteogenic differentiation capacity which might be due to the natural collagen and hydroxyapatite content of DB particles. Alkaline phosphatase activity is increased significantly by using DB particles, notably, without an osteogenic induction of the cells. Moreover, fluorescence images display pronounced cell-material interaction and cell attachment inside the constructs. With these promising results, the present minimalistic bioink formulation is envisioned as a potential candidate for bone tissue engineering as a clinically translatable material with straightforward preparation and high cell activity.


  • Open Access

    Oxygen-sensitive nanoparticles reveal the spatiotemporal dynamics of oxygen reduction during magnesium implant biodegradation

    by Berit Zeller-Plumhoff, Ashwini Rahul Akkineni, Heike Helmholz, Dmytro Orlov, Maria Mosshammer, Michael Kühl, Regine Willumeit-Römer, Michael Gelinsky

    Magnesium (Mg) alloys are becoming increasingly important in the biomedical field as temporary bone implants. However, the biodegradation process of Mg alloys is highly complex and recent findings suggest that oxygen (O2) consumption is non-negligible. In this study, we give experimental proof of O2 consumption during Mg degradation under physiological conditions. Specifically, we study pure Mg, Mg–6 wt%Ag and Mg–5 wt%Gd in Hanks’ balanced salt solution and Dulbecco’s modified Eagle’s medium. We show that O2 consumption and hydrogen evolution are inversely correlated and that O2 concentrations remain below 7.5% in certain cases, which could have significant implications for bone healing.


  • Open Access

    Addition of High Acyl Gellan Gum to Low Acyl Gellan Gum Enables the Blends 3D Bioprintable

    by Ashwini Rahul Akkineni, Bilge Sen Elci, Anja Lode, Michael Gelinsky

    Long-term stability of gellan gum (GG) at physiological conditions is expected, as very low concentration of divalent ions are required for crosslinking, as compared to alginate—which is extensively used for tissue engineering (TE) applications. Hence, GG is proposed as an ideal candidate to substitute alginate for TE. Deacylated (low acyl; LA) GG forms brittle gels, thus only low concentrations were used for cell encapsulation, whereas acylated (high acyl; HA) GG forms weak/soft gels. 3D bioprinting using pure LAGG or HAGG is not possible owing to their rheological properties. Here, we report development and characterization of bioprintable blends of LAGG and HAGG. Increase in HAGG in the blends improved shear recovery and shape fidelity of printed scaffolds. Low volumetric swelling observed in cell culture conditions over 14 days indicates stability. Volumetric scaffolds were successfully printed and their mechanical properties were determined by uniaxial compressive testing. Mesenchymal stem cells bioprinted in blends of 3% LAGG and 3% HAGG survived the printing process showing >80% viability; a gradual decrease in cell numbers was observed over 21 days of culture. However, exploiting intrinsic advantages of 3D bioprinting, LAGG/HAGG blends open up numerous possibilities to improve and/or tailor various aspects required for TE.


  • Open Access

    Controlled and Local Delivery of Antibiotics by 3D Core/Shell Printed Hydrogel Scaffolds to Treat Soft Tissue Infections

    by Ashwini Rahul Akkineni, Janina Spangenberg, Michael Geissler, Saskia Reichelt, Hubert Buechner, Anja Lode, Michael Gelinsky

    Soft tissue infections in open fractures or burns are major cause for high morbidity in trauma patients. Sustained, long-term and localized delivery of antimicrobial agents is needed for early eradication of these infections. Traditional (topical or systemic) antibiotic delivery methods are associated with a variety of problems, including their long-term unavailability and possible low local concentration. Novel approaches for antibiotic delivery via wound coverage/healing scaffolds are constantly being developed. Many of these approaches are associated with burst release and thus seldom maintain long-term inhibitory concentrations. Using 3D core/shell extrusion printing, scaffolds consisting of antibiotic depot (in the core composed of low concentrated biomaterial ink 3% alginate) surrounded by a denser biomaterial ink (shell) were fabricated. Denser biomaterial ink (composed of alginate and methylcellulose or alginate, methylcellulose and Laponite) retained scaffold shape and modulated antibiotic release kinetics. Release of antibiotics was observed over seven days, indicating sustained release characteristics and maintenance of potency. Inclusion of Laponite in shell, significantly reduced burst release of antibiotics. Additionally, the effect of shell thickness on release kinetics was demonstrated. Amalgamation of such a modular delivery system with other biofabrication methods could potentially open new strategies to simultaneously treat soft tissue infections and aid wound regeneration.


  • Three-dimensional bioprinting of volumetric tissues and organs

    by David Kilian, Tilman Ahlfeld, Ashwini Rahul Akkineni, Anja Lode, Michael Gelinsky


  • Open Access

    Highly Concentrated Alginate-Gellan Gum Composites for 3D Plotting of Complex Tissue Engineering Scaffolds

    by Ashwini Rahul Akkineni, Tilman Ahlfeld, Alexander Funk, Anja Waske, Anja Lode, Michael Gelinsky

    In tissue engineering, additive manufacturing (AM) technologies have brought considerable progress as they allow the fabrication of three-dimensional (3D) structures with defined architecture. 3D plotting is a versatile, extrusion-based AM technology suitable for processing a wide range of biomaterials including hydrogels. In this study, composites of highly concentrated alginate and gellan gum were prepared in order to combine the excellent printing properties of alginate with the favorable gelling characteristics of gellan gum. Mixtures of 16.7 wt % alginate and 2 or 3 wt % gellan gum were found applicable for 3D plotting. Characterization of the resulting composite scaffolds revealed an increased stiffness in the wet state (15%–20% higher Young’s modulus) and significantly lower volume swelling in cell culture medium compared to pure alginate scaffolds (~10% vs. ~23%). Cytocompatibility experiments with human mesenchymal stem cells (hMSC) revealed that cell attachment was improved—the seeding efficiency was ~2.5–3.5 times higher on the composites than on pure alginate. Additionally, the composites were shown to support hMSC proliferation and early osteogenic differentiation. In conclusion, print fidelity of highly concentrated alginate-gellan gum composites was comparable to those of pure alginate; after plotting and crosslinking, the scaffolds possessed improved qualities regarding shape fidelity, mechanical strength, and initial cell attachment making them attractive for tissue engineering applications.


  • Open Access

    A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering

    by Michal Bartnikowski, Ashwini Rahul Akkineni, Michael Gelinsky, Maria A. Woodruff, Travis J. Klein

    The concept of biphasic or multi-layered compound scaffolds has been explored within numerous studies in the context of cartilage and osteochondral regeneration. To date, no system has been identified that stands out in terms of superior chondrogenesis, osteogenesis or the formation of a zone of calcified cartilage (ZCC). Herein we present a 3D plotted scaffold, comprising an alginate and hydroxyapatite paste, cast within a photocrosslinkable hydrogel made of gelatin methacrylamide (GelMA), or GelMA with hyaluronic acid methacrylate (HAMA). We hypothesized that this combination of 3D plotting and hydrogel crosslinking would form a high fidelity, cell supporting structure that would allow localization of hydroxyapatite to the deepest regions of the structure whilst taking advantage of hydrogel photocrosslinking. We assessed this preliminary design in terms of chondrogenesis in culture with human articular chondrocytes, and verified whether the inclusion of hydroxyapatite in the form presented had any influence on the formation of the ZCC. Whilst the inclusion of HAMA resulted in a better chondrogenic outcome, the effect of HAP was limited. We overall demonstrated that formation of such compound structures is possible, providing a foundation for future work. The development of cohesive biphasic systems is highly relevant for current and future cartilage tissue engineering.